Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 study evaluating the combination of NXP900 with Osimertinib for advanced EGFR-mutated non-small cell lung cancer is currently recr…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Low-Dose Radiation + SBRT + Tislelizumab Plus Platinum-based Chemotherapy in Stage ⅡA-ⅢB Non-small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial is evaluating a combination of low-dose radiation, SBRT, tislelizumab, and platinum-based chemotherapy for stage II…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA) [Phase 2]
Phase 2 trial evaluating adjuvant cisplatin-based chemotherapy plus concurrent atezolizumab in resected non-small cell lung cancer, with cir…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Parametric Imaging in Positron Emission Tomography for Patient With Lung Cancer [NA]
The clinical trial evaluating parametric imaging in positron emission tomography for a patient with Non-Small Cell Lung Cancer has completed…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Phase II Study of Durvalumab ,Doxorubicin, and Ifosfamide in Pulmonary Sarcomatoid Carcinoma [Phase 2]
Phase II study evaluating the combination of durvalumab, doxorubicin, and ifosfamide in pulmonary sarcomatoid carcinoma (a form of non-small…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Lazertinib for NSCLC Harboring Activating EGFR Mutations in TKI naïve Patients [Phase 2]
A Phase 2 clinical trial evaluating lazertinib in treatment-naïve non-small cell lung cancer with activating EGFR mutations; the study is cu…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: The HER Project: HRD in EGFR-mutated NSCLC
An update on an ongoing clinical trial investigating homologous recombination deficiency in EGFR-mutated non-small cell lung cancer using a …
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: A Phase II Clinical Trial of DZD9008 in Combination With AZD4205 in Standard Treatment Failed NSCLC Patients With EGFR Mutations (WU-KONG21) [Phase 2]
Phase II trial evaluating the combination of DZD9008 with AZD4205 in NSCLC patients with EGFR mutations who failed standard therapy is curre…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Sleeve Lobectomy Following Neoadjuvant Therapy in NSCLC
Clinical trial update notes sleeve lobectomy after neoadjuvant therapy for non-small cell lung cancer; study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR) [NA]
A clinical trial (NCT06524427) is recruiting to compare robot-assisted lobectomy versus video-assisted lobectomy for non-small cell lung can…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Ladarixin With Sotorasib in Advanced NSCLC [Phase 1]
A Phase 1 clinical trial update notes the combination of ladarixin with sotorasib for advanced non-small cell lung cancer with KRAS G12C mut…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Study for Evaluating the Safety and Feasibility of Fecal Microbiota Transplant in Stage II-III NSCLC Patients Using ICI Responders as Donors (MIGRANT) [Phase 2]
A Phase 2 clinical trial (MIGRANT) is evaluating the safety and feasibility of fecal microbiota transplant in stage II-III non-small cell lu…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Description of Neurocognitive and Psychiatric Disorders Associated With Targeted Therapies Used in the Treatment of Lung Cancers With ALK/ROS1 Fusion and Their Impact on Patients' Quality of Life: Construction of an Experimental Patient-researcher Collaborative Care and Research Pathway
This clinical trial update outlines a study examining neurocognitive and psychiatric side effects of ALK/ROS1-targeted therapies in metastat…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN2) [Phase 1]
A Phase 1 trial evaluating DZD6008, an oral EGFR inhibitor from Dizal Pharmaceuticals, in patients with advanced non-small cell lung cancer …
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Bolstering Outcomes After Induction With Osimertinib Plus Chemotherapy Through Optimized Site-Directed Primary Tumor Therapy (BOOST Trial) [Phase 2]
Phase 2 trial evaluating Osimertinib plus chemotherapy with optimized site-directed primary tumor therapy to improve outcomes in non-small c…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Neoadjuvant SBRT Followed by Sintilimab Plus Chemotherapy for N3-Positive NSCLC [Phase 2]
This is a Phase 2 neoadjuvant trial of SBRT followed by sintilimab plus chemotherapy for N3-positive locally advanced non-small cell lung ca…
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
A clinical trial update describing validation of molecular diagnostic assays that detect cancer biomarkers in blood and primary tumors. The …
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: The Construction and Clinical Application of an Integrated Perioperative Management System for Lung Cancer Based on Wearable Devices and Intelligent Platforms [NA]
This document reports on the development and planned clinical use of an integrated perioperative management system for lung cancer using wea…
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors [Phase 1]
First-in-human Phase 1 study of JAB-3312 in adults with advanced solid tumors has been completed, evaluating multiple tumor indications.
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: A Phase II Clinical Study of SKB571 as Monotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With MET Abnormalities [Phase 2]
Phase II clinical trial of SKB571 as monotherapy for locally advanced or metastatic non-small cell lung cancer with MET abnormalities; the s…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
An observational basket trial sponsored by Elephas aims to collect tissue to develop and train a live tumor diagnostic platform across multi…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Molecular Analysis of Thoracic Malignancies
This clinical trial update describes ongoing molecular analyses of thoracic malignancies, including thymic tumors and thoracic carcinomas, w…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases [Phase 2]
A Phase 2 clinical trial is assessing furmonertinib in combination with intrathecal chemotherapy and stereotactic radiotherapy for EGFR-muta…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study of HBI-8000 (tucidinostat) in combination with pembrolizumab for non-small cell lung cancer was terminated. Results have been …
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Observational Lung Trial to Collect Tissue to Train and Validate a Live Tumor Diagnostic Platform
An observational lung cancer trial is recruiting to collect tissue samples to train and validate a live tumor diagnostic platform. The study…